WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong
· Delayed Price · Currency is HKD 26.00
+1.70 (7.00%)
Feb 21, 2025, 4:08 PM HKT
WuXi Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 106,515 | 124,993 | 252,882 | 390,943 | 419,914 | 127,705 | Upgrade
|
| Market Cap Growth | -69.97% | -50.57% | -35.31% | -6.90% | 228.82% | 107.71% | Upgrade
|
| Enterprise Value | 105,466 | 122,776 | 247,673 | 380,146 | 418,224 | 124,541 | Upgrade
|
| Last Close Price | 26.00 | 29.60 | 59.85 | 92.55 | 102.80 | 32.88 | Upgrade
|
| PE Ratio | 40.34 | 33.37 | 50.61 | 93.99 | 209.36 | 112.60 | Upgrade
|
| Forward PE | 24.52 | 22.71 | 37.41 | 77.91 | 168.15 | 80.23 | Upgrade
|
| PS Ratio | 5.85 | 6.66 | 14.65 | 30.95 | 63.00 | 28.66 | Upgrade
|
| PB Ratio | 2.47 | 2.58 | 6.18 | 9.74 | 16.92 | 8.85 | Upgrade
|
| P/TBV Ratio | 1.15 | 2.96 | 6.78 | 10.56 | 17.69 | 9.37 | Upgrade
|
| P/FCF Ratio | - | 182.37 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 13.85 | 24.31 | 40.37 | 92.82 | 187.95 | 94.50 | Upgrade
|
| PEG Ratio | 2.65 | 1.39 | 1.03 | 1.99 | 3.92 | 1.75 | Upgrade
|
| EV/Sales Ratio | 5.73 | 6.54 | 14.35 | 30.10 | 62.75 | 27.95 | Upgrade
|
| EV/EBITDA Ratio | 20.73 | 22.61 | 43.22 | 85.50 | 198.82 | 97.54 | Upgrade
|
| EV/EBIT Ratio | 28.45 | 28.34 | 50.36 | 97.69 | 234.41 | 117.44 | Upgrade
|
| EV/FCF Ratio | -314.63 | 179.13 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.12 | 0.13 | 0.16 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.96 | 0.89 | 0.86 | 1.18 | 1.85 | 1.88 | Upgrade
|
| Debt / FCF Ratio | - | 7.33 | - | - | - | - | Upgrade
|
| Asset Turnover | 0.32 | 0.32 | 0.33 | 0.28 | 0.24 | 0.30 | Upgrade
|
| Inventory Turnover | 5.35 | 5.04 | 4.31 | 3.94 | 4.15 | 7.42 | Upgrade
|
| Quick Ratio | 2.40 | 2.35 | 1.55 | 1.85 | 2.49 | 2.93 | Upgrade
|
| Current Ratio | 2.91 | 2.78 | 1.98 | 2.37 | 3.16 | 3.37 | Upgrade
|
| Return on Equity (ROE) | 7.20% | 8.90% | 13.20% | 13.09% | 10.02% | 9.67% | Upgrade
|
| Return on Assets (ROA) | 3.98% | 4.63% | 5.81% | 5.43% | 4.03% | 4.39% | Upgrade
|
| Return on Capital (ROIC) | 4.61% | 5.51% | 7.00% | 6.47% | 4.78% | 5.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.00% | 8.04% | 10.81% | 8.86% | 6.14% | 6.44% | Upgrade
|
| Earnings Yield | 2.66% | 3.00% | 1.98% | 1.06% | 0.48% | 0.89% | Upgrade
|
| FCF Yield | -0.31% | 0.55% | -0.15% | -0.97% | -1.17% | -1.75% | Upgrade
|
| Buyback Yield / Dilution | 1.28% | 0.62% | 1.04% | -5.05% | -5.30% | -1.41% | Upgrade
|
| Total Shareholder Return | 1.28% | 0.62% | 1.04% | -5.05% | -5.30% | -1.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.